Oraee-Yazdani, Saeed
Akhlaghpasand, Mohammadhosein
Shokri, Gelareh
Rostami, Fatemeh
Golmohammadi, Maryam
Jamshidi-Adegani, Fatemeh
Arefian, Ehsan
Hafizi, Maryam
Zomorrod, Mina Soufi
Oraee-Yazdani, Maryam
Zali, Ali-Reza
Soleimani, Masoud
Article History
Received: 25 December 2020
Accepted: 13 April 2021
First Online: 22 May 2021
Declarations
:
: This study was designed in line with the declaration of Helsinki and was approved by the Ethics committee in the Medical Research Committee of the Shahid Beheshti University of Medical Sciences; license number: IR.SBMU.REC.1396.224 and clinical trial registration number: IRCT20200502047277N2. All procedures were performed after written informed consent was obtained. Written consent included procedures of culture and analyses of biopsies from the tissue. Patients were fully aware of the experimental process of the treatment, unexpected outcomes, and possible or unforeseen adverse effects.
: Patients have consented to the submission of the present study to the journal.
: The authors declare no competing interests.